Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. "Without recourse" is a term used in financial agreements to indicate that one party cannot ...
Last year, a team of American diplomats from the State Department’s Global Engagement Center traveled to two dozen countries and signed a series of memoranda. Along with their counterparts in places ...
The doctor who died by suicide in Maharashtra's Satara and accused a police officer of raping her four times also left behind a four-page suicide letter in which she said she was pressured to issue ...
The Haryana government on Saturday transferred Rohtak Superintendent of Police Narendra Bijarniya, days after IPS officer Y Puran Kumar allegedly shot himself dead at his Chandigarh residence, ...
In a separate development, Lendway entered into unsecured promissory notes totaling $4 million with Air T, Inc., AO Partners I, L.P., and Gary S. Kohler. The notes carry a fixed annual interest rate ...
DCG sues Genesis entities for overpayments made on a $1.1 billion note tied to 3AC’s default. The promissory note was issued in 2022 to cover potential losses from 3AC’s collapse. Genesis allegedly ...
WASHINGTON, DC / ACCESS Newswire / August 5, 2025 / Lanny J. Davis, legal counsel to Oxford Gray Corporation of North America, announced today that FINTIV, a Texas-based company led by Michael Liberty ...
MANHATTAN, New York (WABC) -- The 27-year-old man who shot and killed four people at a Midtown office building on Monday carried a note in his pocket claiming he suffered from CTE, asked that his ...
Four people were killed in a shooting Monday evening inside a New York City office building. The gunman, who used a high-powered rifle to open fire in the Midtown Manhattan skyscraper, later died of a ...
ZDNET experts put every product through rigorous testing and research to curate the best options for you. If you buy through our links, we may earn a commission. Learn Our Process 'ZDNET Recommends': ...
Indaptus Therapeutics announces $2.3 million from convertible promissory notes, seeking total $5 million for R&D and operations. Indaptus Therapeutics, Inc. announced the sale of approximately $2.3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results